Short answer
Alkermes plc. (ALKS) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $480M (up 21.8% year over year) with net income of $16M.
Q3 2026 key financials · XBRL
- Revenue
- $480M
- +21.8% YoY · −3.2% QoQ
- Net income
- $16M
- −80.3% YoY · +3150.9% QoQ
- Operating margin
- 7.5%
- EPS (diluted)
- $0.10
- −79.6% YoY
Source: XBRL data from the Alkermes plc. (ALKS) Q3 2026 10-Q on SEC EDGAR. USD.
Alkermes plc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $480.2M, up $85.9M YoY, driven by LUMRYZ addition
- Product sales $417.3M vs $317.4M, with LUMRYZ $89.9M, best-performing product
- LYBALVI $95.9M vs $98.2M, worst product performance, down $2.3M YoY
- Net income $16.3M vs $82.8M, operating expenses up $139.0M and interest expense up $27.6M
- Cash $631.3M, operating cash flow $72.9M, Avadel acquisition cash consideration $2,199.2M; existing liquidity expected sufficient 12 months
Risk Factors
- No material changes disclosed, with risk factors incorporated by reference to the Annual Report
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Alkermes plc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.